newsfilter
← Latest News
ClinicalTrials.gov·

Tafasitamab, Lenalidomide and Venetoclax for the Treatment of Relapsed or Refractory Mantle Cell Lymphoma - NCT05910801

Objective response rate, Complete response rate, Duration of response, (and 3 more...)